Search results
Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDA | JD Supra
JD Supra· 12 hours agoThe companies announced in June 2023 that they had reached a settlement and license agreement with Johnson & Johnson, which granted a license entry date for Selarsdi™ in the U.S. by February ...
How Is Ulcerative Colitis Treated?
Health via Yahoo News· 6 days agoIntegrin receptor agonists: Tysabri (natalizumab) and Entyvio (vedolizumab) prevent inflammatory cells from moving into the intestinal lining by blocking a protein on the cells' surfaces. Anti-interleukin ...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 7 days agoDENVER (KDVR) — A Colorado board continues reviewing the cost of prescription drugs, and public...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 5 days agoJ&J Begins Q1 Earnings Season: J&J’s first-quarter results were mixed as it beat estimates for...
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 18 hours agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
Investor's Business Daily· 5 days agoAbbott's EPS declined 5%, while J&J's rose 12%. Abbott beat sales forecasts, but issued light...
Top Stock Reports for NVIDIA, Alphabet & Johnson & Johnson
Zacks via Yahoo Finance· 6 days agoToday's Research Daily features new research reports on 16 major stocks, including NVIDIA...
Analyst updates Johnson & Johnson stock price target after earnings
TheStreet via Yahoo Finance· 5 days ago“While sequential growth was roughly flat due to phasing, we continue to anticipate...
FDA requires changes to CAR-T cell therapy boxed warning (NYSE:BMY)
Seeking Alpha· 5 days agoThe FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk of...
What’s Next For Johnson & Johnson Stock After Beating Q1 Earnings?
Forbes· 6 days agoJohnson & Johnson (NYSE: JNJ) recently reported its Q1 results, with revenues marginally below but...
